Scott Wapner is host of the "Fast Money Halftime Report," which airs weekdays from 12PM to 1PM ET.
He has reported live from the floor of the New York Stock Exchange and the Nasdaq MarketSite, covering the real-time action of the global financial markets. Wapner was reporting live from the New York Stock Exchange during the May 2010 "flash crash."
Wapner has also reported several documentaries for the network, including "Hotel: Behind Closed Doors at Marriott," "Ultimate Fighting: From Blood Sport to Big Time," which earned him an Emmy nomination, and "One Nation, Overweight," which documents the impact of the nation's obesity epidemic. In 2011, Wapner received an award from the Society of American Business Editors and Writers as well as a Sigma Delta Chi Award from the Society of Professional Journalists for "One Nation, Overweight."
Before joining CNBC, Wapner served as the franchise Business Reporter for KDFW-TV in Dallas and was a reporter for Associated Press Television News, based in New York City.
Wapner earned a bachelor's degree in history from the University of South Florida.
Follow Scott Wapner on Twitter @ScottWapnercnbc.
Mike Mayo, CLSA research analyst and managing director, discusses the battle over Comerica and his call for change.
What's to come for Apple next week, when they hold their big event September 7? Also, Richmond Fed President Jeffrey Lacker speaks on the Fed's economic outlook following today's jobs report. CNBC's Steve Liesman reports. The "Fast Money Halftime Report" traders, John Spallanzani, GFI Group chief macro strategist, and Barbara Doran, Yorkbridge director and senior portfolio manager, weigh in.
The "Fast Money Halftime Report" traders, John Spallanzani, GFI Group chief macro strategist, and Barbara Doran, Yorkbridge director and senior portfolio manager, take their positions on five stocks making news today, including Gap, Broadcom and more.
CNBC's Meg Tirrell reports the latest on Mylan and their response to a letter from U.S. Sen. Amy Klobuchar (D-Minn.) saying Centers for Medicare and Medicaid Services (CMS) has “found that Mylan misclassified the EpiPen” as a “non-innovator” drug.
Chris Raymond, Raymond James managing director and senior biotech analyst, shares his bullish take on Abbvie. The "Fast Money Halftime Report" traders and Barbara Doran, Yorkbridge director and senior portfolio manager, weigh in.
According to Bloomberg, Mylan may have misclassified its EpiPen product under certain Medicaid guidelines. CNBC's Dominic Chu reports the details. John Spallanzani, GFI Group chief macro strategist, and the "FMHR" traders weigh in.
The "Halftime Report" traders discuss Goldman's call to sell Dunkin' Brands.
Snap getting a host of Street initiations on Monday. Stifel's Scott Devitt joined the "Halftime Report" to make the case for his "hold" rating.
What could make retail stocks feel even more pain
Big movers in the Tuesday blitz
Blitz stocks on a bad day for the market
The "Halftime Report" traders take you through some of the day's biggest movers.
"Halftime Report" regular Pete Najarian is tracking the options market for signs of unusual trading.
Pete Najarian spots unusual options activity in Energy Transfer Partners.
Pete Najarian spots unusual activity in CSX.